HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoblastic lymphadenopathy-like T cell lymphoma evolving into a massive plasma cell proliferation with biclonal paraproteinemia.

Abstract
We present a case of immunoblastic lymphadenopathy-like T cell lymphoma (IBL-T) who subsequently developed a massive proliferation of plasma cells. At diagnosis of IBL-T, the patient had polyclonal hypergammaglobulinemia and subsequently, while on chemotherapy, developed paraproteinemia with biclonal peaks and the IBL-T lesion was replaced with a massive proliferation of CD38-positive plasma cells. The evolution was not likely to be attributed to a new neoplastic proliferation of B cells. It appeared that two B cell clones possibly had a growth advantage among the polyclonal B cells due to a depletion of suppressor T cells or to a disturbance in the immune system.
AuthorsT Higuchi, J Tada, H Mori, H Niikura, M Omine, K Kishimoto, G Tate, T Mitsuya
JournalActa haematologica (Acta Haematol) Vol. 100 Issue 3 Pg. 151-5 (Dec 1998) ISSN: 0001-5792 [Print] Switzerland
PMID9858793 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation
  • Membrane Glycoproteins
  • ADP-ribosyl Cyclase
  • CD38 protein, human
  • NAD+ Nucleosidase
  • ADP-ribosyl Cyclase 1
Topics
  • ADP-ribosyl Cyclase
  • ADP-ribosyl Cyclase 1
  • Aged
  • Antigens, CD
  • Antigens, Differentiation
  • Cell Division
  • Female
  • Flow Cytometry
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Hypergammaglobulinemia (complications, immunology)
  • Immunoblastic Lymphadenopathy (complications, immunology)
  • Lymphoma, T-Cell (complications, immunology)
  • Membrane Glycoproteins
  • NAD+ Nucleosidase
  • Paraproteinemias (complications, immunology)
  • Plasma Cells (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: